Repression of virulence genes by phosphorylation‐dependent oligomerization ofCsrR at target promoters in S. pyogenes

csrRS encodes a two‐component regulatory system that represses the transcription of a number of virulence factors in Streptococcus pyogenes, including the hyaluronic acid capsule and pyrogenic exotoxin B. CsrRS‐regulated virulence factors have diverse functions during pathogenesis and are differentially expressed throughout growth. This suggests that multiple signals induce CsrRS‐mediated gene regulation, or that regulated genes respond differently to CsrR, or both. As a first step in dissecting the csrRS signal transduction pathway, we determined the mechanism by which CsrR mediates the repression of its target promoters. We found that phosphorylated CsrR binds directly to all but one of the promoters of its regulated genes, with different affinities. Phosphorylation of CsrR enhances both oligomerization and DNA binding. We defined the binding site of CsrR at each of the regulated promoters using DNase I and hydroxyl radical footprinting. Based on these results, we propose a model for differential regulation by CsrRS.

[1]  V. DiRita,et al.  Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. , 2001, The Journal of infectious diseases.

[2]  J. Cohen,et al.  Mitogenic factor (MF) is the major DNase of serotype M89 Streptococcus pyogenes. , 2000, Microbiology.

[3]  M. Cunningham,et al.  Pathogenesis of group A streptococcal infections. , 2000, Clinical microbiology reviews.

[4]  K. Bettenbrock,et al.  Cysteine protease SpeB expression in group A streptococci is influenced by the nutritional environment but SpeB does not contribute to obtaining essential nutrients , 1999, Medical Microbiology and Immunology.

[5]  Jonathan D. Cohen,et al.  Growth-Phase-Dependent Expression of Virulence Factors in an M1T1 Clinical Isolate of Streptococcus pyogenes , 1999, Infection and Immunity.

[6]  V. DiRita,et al.  A Two-Component Regulatory System, CsrR-CsrS, Represses Expression of Three Streptococcus pyogenesVirulence Factors, Hyaluronic Acid Capsule, Streptolysin S, and Pyrogenic Exotoxin B , 1999, Infection and Immunity.

[7]  B. Kreikemeyer,et al.  Identification of pel, aStreptococcus pyogenes Locus That Affects both Surface and Secreted Proteins , 1999, Journal of bacteriology.

[8]  June R. Scott,et al.  Regulation of mga Transcription in the Group A Streptococcus: Specific Binding of Mga within Its Own Promoter and Evidence for a Negative Regulator , 1999, Journal of bacteriology.

[9]  M. Federle,et al.  A Response Regulator That Represses Transcription of Several Virulence Operons in the Group A Streptococcus , 1999, Journal of bacteriology.

[10]  M. Chaussee,et al.  The rgg Gene of Streptococcus pyogenes NZ131 Positively Influences Extracellular SPE B Production , 1999, Infection and Immunity.

[11]  I. van de Rijn,et al.  Characterization of a Two-component System in Streptococcus pyogenes Which Is Involved in Regulation of Hyaluronic Acid Production* , 1999, The Journal of Biological Chemistry.

[12]  A. Podbielski,et al.  Characterization of nra, a global negative regulator gene in group A streptococci , 1999, Molecular microbiology.

[13]  M. Caparon,et al.  A role for Trigger Factor and an Rgg‐like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes , 1998, The EMBO journal.

[14]  M. Wessels,et al.  Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus , 1998, Molecular microbiology.

[15]  P. Tsai,et al.  Role of Streptococcal Pyrogenic Exotoxin B in the Mouse Model of Group A Streptococcal Infection , 1998, Infection and Immunity.

[16]  M. Wessels,et al.  Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. , 1998, The Journal of clinical investigation.

[17]  D. Low,et al.  Reduced Virulence of Group A Streptococcal Tn916 Mutants That Do Not Produce Streptolysin S , 1998, Infection and Immunity.

[18]  M. Bolander,et al.  Direct sequencing of unpurified PCR-amplified DNA by semi-exponential cycle sequencing (SECS) , 1997, Molecular biotechnology.

[19]  R M Williams,et al.  Molecular aspects of the E. coli nucleoid protein, H-NS: a central controller of gene regulatory networks. , 1997, FEMS microbiology letters.

[20]  J. Musser,et al.  Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. , 1997, The Journal of clinical investigation.

[21]  M. Chaussee,et al.  Temporal production of streptococcal erythrogenic toxin B (streptococcal cysteine proteinase) in response to nutrient depletion , 1997, Infection and immunity.

[22]  C. Gualerzi,et al.  The oligomeric structure of nucleoid protein H‐NS is necessary for recognition of intrinsically curved DNA and for DNA bending , 1997, The EMBO journal.

[23]  H. Ingmer,et al.  H‐NS: a modulator of environmentally regulated gene expression , 1997, Molecular microbiology.

[24]  M. Inouye,et al.  Signal transduction via the histidyl‐aspartyl phosphorelay , 1997, Genes to cells : devoted to molecular & cellular mechanisms.

[25]  R. Kadner,et al.  Protein Phosphorylation Affects Binding of the Escherichia coli Transcription Activator UhpA to the uhpT Promoter* , 1997, The Journal of Biological Chemistry.

[26]  M. Wessels,et al.  Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus , 1997, Infection and immunity.

[27]  A. Podbielski,et al.  What is the size of the group A streptococcal vir regulon? The Mga regulator affects expression of secreted and surface virulence factors , 1996, Medical Microbiology and Immunology.

[28]  E. Kaplan.  Recent epidemiology of group A streptococcal infections in North America and abroad: an overview. , 1996, Pediatrics.

[29]  J. Musser,et al.  Substitution of cysteine 192 in a highly conserved Streptococcus pyogenes extracellular cysteine protease (interleukin 1beta convertase) alters proteolytic activity and ablates zymogen processing , 1996, Infection and immunity.

[30]  A. Ullmann,et al.  Phosphorylation‐dependent binding of BvgA to the upstream region of the cyaA gene of Bordetella pertussis , 1996, Molecular microbiology.

[31]  Lucy Shapiro,et al.  Cell Cycle Control by an Essential Bacterial Two-Component Signal Transduction Protein , 1996, Cell.

[32]  M. Wessels,et al.  Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Nemoto,et al.  Cysteine protease activity of streptococcal pyrogenic exotoxin B. , 1994, Canadian journal of microbiology.

[34]  D. Kahn,et al.  Phosphorylation of the Rhizobium meliloti FixJ protein induces its binding to a compound regulatory region at the fixK promoter. , 1994, The Journal of biological chemistry.

[35]  M. Caparon,et al.  The identification of rofA, a positive‐acting regulatory component of prtF expression: use of an mγδ‐based shuttle mutagenesis strategy in Streptococcus pyogenes , 1994 .

[36]  B. Dougherty,et al.  Molecular characterization of hasA from an operon required for hyaluronic acid synthesis in group A streptococci. , 1994, The Journal of biological chemistry.

[37]  M. Chaussee,et al.  Inactivation of the streptococcal erythrogenic toxin B gene (speB) in Streptococcus pyogenes , 1993, Infection and immunity.

[38]  D. Musher,et al.  Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). , 1993, The Journal of infectious diseases.

[39]  T. Yutsudo,et al.  A new type of mitogenic factor produced by Streptococcus pyogenes , 1992, FEBS letters.

[40]  M. Boyle,et al.  Streptokinase-producing streptococci grown in human plasma acquire unregulated cell-associated plasmin activity. , 1992, The Journal of infectious diseases.

[41]  M. Inouye,et al.  Phosphorylation of OmpR by the osmosensor EnvZ modulates expression of the ompF and ompC genes in Escherichia coli. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[42]  V. Weiss,et al.  Phosphorylation of nitrogen regulator I (NRI) of Escherichia coli. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Kenji Oosawa,et al.  Phosphorylation of three proteins in the signaling pathway of bacterial chemotaxis , 1988, Cell.

[44]  M. Caparon,et al.  Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[45]  H. Drew,et al.  DNA structural variations in the E. coli tyrT promoter , 1984, Cell.

[46]  Hen-Ming Wu,et al.  The locus of sequence-directed and protein-induced DNA bending , 1984, Nature.

[47]  V. DiRita,et al.  Bacterial virulence gene regulation: an evolutionary perspective. , 2000, Annual review of microbiology.

[48]  M. Chaussee,et al.  The rgg gene of Streptococcus pyogenes NZ131 positively influences extracellular SPE B production. , 1999, Infection and immunity.

[49]  V. de Lorenzo,et al.  Clues and consequences of DNA bending in transcription. , 1997, Annual review of microbiology.

[50]  D. Feingold,et al.  Group A streptococcal infections. An old adversary reemerging with new tricks? , 1996, Archives of dermatology.

[51]  P. Schlievert,et al.  Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. , 1996, The Journal of laboratory and clinical medicine.

[52]  H. Müller-Alouf,et al.  [Cellular constituents and extracellular proteins involved in the pathogenic capacity of Streptococcus group A]. , 1996, Annales pharmaceutiques francaises.

[53]  M. Caparon,et al.  The identification of rofA, a positive-acting regulatory component of prtF expression: use of an m gamma delta-based shuttle mutagenesis strategy in Streptococcus pyogenes. , 1994, Molecular microbiology.

[54]  D. Stevens.  Invasive group A streptococcus infections. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  J. Alouf,et al.  Production, purification, and assay of streptolysin S. , 1988, Methods in enzymology.

[56]  M. Churchill,et al.  Hydroxyl radical footprinting: a high-resolution method for mapping protein-DNA contacts. , 1987, Methods in enzymology.